Melatonin Use for Sleep in Autistic Children: Balancing Benefits and Evidence Gaps

Many autistic children experience persistent sleep challenges, with over 50% facing difficulties falling or staying asleep. These patterns can affect daily functioning and family dynamics. While behavioral supports help some, melatonin supplements have become a common option — yet researchers emphasize key evidence gaps remain about their use.

Documented Benefits, Emerging Questions

Clinical trials demonstrate melatonin's short-term efficacy for sleep in autistic children. A 2023 meta-analysis found it significantly reduced time to fall asleep and increased total sleep duration, though specific metrics vary by study. Prolonged-release formulations may help maintain sleep continuity for some.

A 2023 meta-analysis found it significantly reduced time to fall asleep and increased total sleep duration, though specific metrics vary by study.

However, as noted by Science Media Centre España (2026), melatonin use has risen sharply among children under 6 despite being sold as an unregulated supplement in many regions. This raises concerns because:

• Dosing accuracy varies widely in commercial products
• Long-term effects on neurodevelopment are not yet well studied
• Safety data for infants/toddlers is particularly limited

Building Better Evidence

Initiatives like the Simons Sleep Project aim to accelerate research through open-science frameworks. Future studies may clarify:

• Individual response factors (e.g., genetic differences)
• Interactions with other therapies
• Age-specific safety profiles

Clinicians stress that melatonin should complement — not replace — behavioral strategies. As The Lancet (2025)00211-1/abstract) notes, addressing environmental and circadian factors remains foundational for sustainable sleep support.